Scholars Central

Conference abstractPublished 25 Apr 2022

Safe Combination of Cisplatin and Metformin Reverts the Malignant Ascites in a Mouse Model to a Solid Tumor by Downregulation of Np63 and Induces Tumor Dormancy via m TOR/ p21 Mechanism

Authors: Sara Gebril

Clinical Immunology and Infectious Diseases

Volume 6 · Issue 2 · Pages 4

More from this journal

The newest in Clinical Immunology and Infectious Diseases.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Immunology and Infectious Diseases
  • SubjectImmunology & Microbiology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Sara Gebril”